Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical company whose stock has gained nearly 12% in the past week, recently sold 347 ...

Citi analyst David Lebowitz has maintained their bullish stance on MDGL stock, giving a Buy rating yesterday.Invest with Confidence: Follow ...

The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units, as noted ...

Madrigal Pharmaceuticals (MDGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yasmeen ...

Akero's success in reversing cirrhosis follows that of Madrigal, making analysts and investors bullish on drugs to treat ...

Disney On Ice” will make a return to the Hostess City, bringing two of the studio’s animated films to life. From February 28 ...

WEST CONSHOHOCKEN, PA—William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale ...

Infinity Pharmaceuticals Inc. 0.00% $90.76 ...

One of President Trump's first executive orders impacts transgender inmates incarcerated in federal facilities. It's just one ...

2025年1月27日， Madrigal（MDGL）披露4笔公司内部人交易情况。董事Sibold William John于2025年1月24日卖出1584股。

Former “Daily Show” correspondent Al Madrigal returned on Thursday night with a stinging message about immigrants in the United States. “America doesn’t have an immigration policy,” he told Ronny ...